Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Interference with RhoA-ROCK Signaling Mechanism in Autoreactive CD4(+) T Cells Enhances the Bioavailability of 1,25-Dihydroxyvitamin D(3) in Experimental Autoimmune Encephalomyelitis.
Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
An Inventory of Short Term and Long Term Changes in Gene Expression Under Interferon β Treatment of Relapsing Remitting MS Patients.
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
Atypical guillain-barré syndrome misdiagnosed as lumbar spinal stenosis.
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Study Suggests Targeting B Cells May Help with MS
MS related employment and disease modifying treatment in the German working population: 1994-2009.
Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (ALLEGRO)
Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Celiac disease and multiple sclerosis in the northwest of Iran.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Progress in multiple sclerosis research in the last year.

Pages